In this episode of TOGA's Conversations in Lung Cancer Research, host Prof. Shalini Vinod (Radiation Oncologist, Liverpool Hospital, Sydney) and guests Dr. Dasantha Jayamanne (Radiation Oncologist, Royal North Shore Hospital, Sydney, and GenesisCare) and Dr. Jane Ludbrook (Radiation Oncologist, Calvary Mater Hospital, Newcastle) discuss the rapid technological and clinical advancements in thoracic radiation oncology. They cover the evolving roles of Stereotactic Ablative Body Radiotherapy (SABR/SBRT) across different stages of non-small cell lung cancer (NSCLC), recent Australian clinical trial updates, strategies for reducing toxicity, and future directions in radiation therapy.
In this episode of TOGA's Conversations in Lung Cancer Research, host Prof. Shalini Vinod (Radiation Oncologist, Liverpool Hospital, Sydney) and guests Dr. Dasantha Jayamanne (Radiation Oncologist, Royal North Shore Hospital, Sydney, and GenesisCare) and Dr. Jane Ludbrook (Radiation Oncologist, Calvary Mater Hospital, Newcastle) discuss the rapid technological and clinical advancements in thoracic radiation oncology. They cover the evolving roles of Stereotactic Ablative Body Radiotherapy (SABR/SBRT) across different stages of non-small cell lung cancer (NSCLC), recent Australian clinical trial updates, strategies for reducing toxicity, and future directions in radiation therapy.
Trials Mentioned:
PRIME-LUNG: https://thoraciconcology.org.au/news/clinical-trials/prof-siva-receives-1-5m-funding-for-prime-lung/
MODERN LUNG: https://thoraciconcology.org.au/clinical-trials/25-003-modern-lung/
(00:00) Welcome and Overview
(02:38) SABR Basics and Eligibility
(04:17) SABR for Operable Patients
(05:31) SABR Advances and Short Courses
(07:33) SABR in Stage III and IV
(14:08) Immunotherapy with Early SABR
(16:02) Modern Tech for Stage III RT
(20:25) New Organs at Risk
(23:49) Australian Trials Vital and Modern Lung
(27:51) Access for Rural Patients
(30:06) Future of Lung Radiotherapy
(35:00) Closing and Call to Action